Aseptic loosening of implants or loosening due to persistent bacterial infection remains a severe complication in orthopaedic surgery. To investigate underlying cellular and molecular mechanisms, particularly with regard to bone loss, tissue samples of patients requiring surgery were examined. By histological methods and by quantitative RT-PCR, respectively, infiltration of leukocytes, expression of osteoclast-typical genes and of proinflammatory cytokines was determined. Samples were taken directly from osteolytic sites and for comparison from adjacent sites, distant sites and from muscle. At osteolytic sites, cathepsin K and the metalloproteinases MMPI and MMP9 were found, as was expression of inflammation-related cytokines, particularly of interleukin (IL)-lO, CXCL8, SlOOA9 and a very moderate expression of receptor activator of NfKB ligand (RANKL) and tumour necrosis factor (TNF)
in low-grade, persistent infection. Bacteria may form biofilms which adhere firmly to the implant und thus escape detection in aspirates, swabs or tissue samples (4) . Moreover, septic but also aseptic loosening, is invariably associated with an activation of local host defence mechanisms, although the number and the composition of the cellular infiltrate varies (5) (6) (7) . Most likely, phagocytosis is a common denominator, because bacteria, but also wear particles, are taken up by monocytic cells or also in case of infection by neutrophils. Phagocytosis is associated with synthesis and release of a variety of cytokines, generating a proinflammatory environment which is responsible for the persistence and the progression of the inflammatory response, as well as for the generation of osteoclasts.
Inthis study, we addressed the question whether the local tissue response in patients with aseptic loosening might differ from that of patients with implantassociated bacterial infections. Because loss of bone matrix occurs in both aseptic loosening and implantassociated osteomyelitis, we focused on expression of cathepsin K as a marker for the generation of osteoclasts (8) , and on proinflammatory cytokines with the potential to induce generation of osteoclasts from precursor cells, including receptor activator of NfKB (RANK) ligand, CXCL2 (macrophage inflammatory protein (MIP)2a), tumor necrosis factor (TNF)a, interleukin (IL)-l and CXCL8 (IL-8) (9), (10 and references therein). Furthermore, cytokines indicative of monocyte or T-cell activation such as Sl00A9 (MRPI4), CCL-2 (MCP-I), and CXCLIO (IP-I0) were analysed in both conditions.
We found a high expression of cathepsin K at osteolytic sites compared to distant sites or muscle, and evidence for the generation of proinflammatory and osteoclast inducing cytokines, the latter more prominent in infected tissue.
MATERIALS AND METHODS

Patients
Fourteen patients undergoing revision surgery due to aseptic loosening and 10 patients with infected implants were included in the study. Diagnosis of loosening was based on patient's complaints, clinical examination, by conventional x-ray and/or CT-scan, and the lack of signs of infection. Diagnosis of infected implants was based on clinical evaluation (reddening, swelling, hyperthermia, pain, pus intraoperatively, existence of a sinus tract) and laboratory results (elevated CRP concentrations and white blood cell count); at least three of these criteria or detection of bacteria in at least two intraoperative tissue samples and/or a positive result after implant-sonication was required for diagnosis of implant infection (clinical data are summarised in Table I ). The study was approved by the ethics committee of the University of Heidelberg (case number S-424/201O), and informed consent was obtained from the patients.
Collection oftissue samples
During surgery, tissue samples from various sites around the implant were taken in a standardized manner: one sample was taken from the site with the most prominent osteolysis, and another sample from a site adjacent to the osteolysis. Samples were taken from the synovia, joint capsule or from an area of the implant component, which did not show osteolysis. A third sample was taken from a distant site, usually the implant component which did not show signs of osteolysis, or in case of loosening of both implant components, from tissue most distant from the site of osteolysis. All were soft tissue samples devoid of bone. By histology, integrity of the tissue was assured. Additionally, a muscle sample was taken, as a control sample which was furthest away from the osteolytic site. Each sample was divided and conserved for histological analysis, microbiological examination or placed into RNAlater (Ambion Cat. # 7021) for quantitative PCR analysis.
Microbiological examination
The tissue was suspended in I ml NaCI (0.9 %), ground with a porcelain mortar and then inoculated onto Columbia 5% sheep blood agar (BD), chocolate agar, MacConkey agar, SCS agar, SNVS Agar (all bioMerieux), or thioglycolate broth (BD). Plates and broth were incubated until positive; either up to 5 days at 36°C in 5% C02 or under anaerobic conditions. For sonication, the explanted prostheses were placed into sterile plastic bags in the operating room. Enough Ringer solution to cover the implant was added (400 mI). The plastic bag was sealed and placed in a second plastic bag. The implants were thus placed in the ultrasound bath (Transsonic TI-H 20, Elma) and treated with the following setting of ultrasonic frequency, power and time: 45 kHz, 100% (250 W) for I min. Twenty ml were taken directly from the ringer solution and divided into an aerobic and an anaerobic blood culture bottle (BD Bactec plus aerobic/ anaerobic, Becton Dickinson).
Histology
The samples were fixed in formalin and embedded in paraffin. Two urn slices were stained either with hematoxylin-eosin or for immunoenzyme staining for expression ofcathespin K, tartrate-resistant acid phosphate (TRAP) and CXCL8 using standard avidin-biotin antialkaline phosphatase techniques (Vectastain; Vector Laboratories). Antigen retrieval was achieved by steamcooking the slides in 10 mM citrate buffer (pH 6.1; Dako) for 30 min. A solution of 10% Earle's balanced salt solution (EBSS, Sigma-Aldrich) supplemented with 1% HEPES, 0.2% BSA, and 0.1% saponin (all from Sigma-Aldrich), pH 7.4, was used as a washing and permeabilisation buffer. Anti-cathepsin K (ab19027), anti-TRAP (an1399953) and anti-CXCL8 (7747) were purchased from Abeam. Primary antibody dilutions also were prepared in this buffer and incubated overnight at 4°C. Biotinylated donkey antirabbit IgG was applied as a secondary reagent for 30 min at room temperature. Naphthol AS-biphosphate (Sigma-Aldrich) with New Fuchsin (Merck) was used as the substrate for alkaline phosphatase.
Gene expression analysis
Tissue was collected in RNAlater (Ambion), disrupted using a RiboLyser device (ThennoHYBAID, Heidelberg) containing 400 /ll lysis buffer from the MagnaPure mRNA Isolation Kit I containing 1%DTT (v/w) (ROCHE Diagnostics, Mannheim). mRNA was isolated with the MagnaPure-LC device. An aliquot of mRNA was reversely transcribed using AMV-RT and oligo-(dT) as primer (First Strand cDNA synthesis kit, Roche) according to the manufacturer's protocol. For PCR analysis, primer sets optimized for the Lightf'ycler" (RAS, Mannheim Germany) were developed by and purchased from SEARCH-LC GmbH (www.Search-LC. com). The PCR was performed with the Lightt.ycler" FastStart DNA Sybr GreenI kit (RAS) according to the protocol provided in the respective parameter. To control for specificity of the amplification products, a melting curve analysis was performed. The copy number was calculated from a standard curve, obtained by plotting known input concentrations of four different plasmids at log dilutions to the PCR-cycle number (CP) at which the detected fluorescence intensity reaches a fixed value. To correct for differences in the content of mRNA, the calculated transcript numbers were normalized according to the expression of the housekeeping gene peptidylprolyl isomerase B (PPIB). Values were thus given as transcripts per 1000 transcripts of PPIB.
Statistical analysis
Comparison between patient groups was made by descriptive analysis, calculating mean values and standard deviation, as well as the median. Data are displayed as boxand-whiskers blot, showing the mean (D) and the median value (horizontal bar) and the highest and lowest values, with the box containing 50 % of the values. Differences between groups (either tissue or patients) were calculated by Friedman test, followed by Mann-Whitney test using Origin 8.6 as software. The association between selected cytokines or receptors, was calculated by Fisher's test, using the number of transcripts in the respective tissues and the median values (obtained when the copy numbers ofthe 4 tissues were summed up) as cut offfor creating the 2x2 contingency table provided by GraphPad software.
RESULTS
Sampling oftissue
An example for sampling of tissue sections during surgery is shown in Fig. 1 . By real time PCR, expression of cathepsin K was determined as marker of osteoclast generation, because it is known to be prominently up-regulated when myeloid precursor cells differentiate to osteoclasts. Moreover, CD 14 as marker for monocytes and CD3 as marker for T cells were determined in the respective tissue, as were the metalloproteinases MMP 1 and MMP9, and cytokines including CXCL8 (IL-8), IL-1B,receptor activator of NfKB (RANK), its ligand (RANKL), TNFa, CX<;:L2 [macrophage inflammatory protein (MIP)-2a], CCL2 (monocyte chemoattractant protein MCP-1), myeloid related protein (MPR)-14 (S100A9) and CXCLlO [interferon gamma induced protein (IP)-10)]. These cytokines were chosen because they are associated with induction of osteoclast generation, or have proinflammatory activities, or are associated with activated monocytes or T cells, respectively (the example in Fig. 1 shows the data obtained for this particular patient with an implant-associated infection).
Osteolysis, cathepsin K, andcytokine gene expression in patients with aseptic loosening
Gene expression of cathepsin K, a marker of osteoclast generation, varied among the individual patients; it, however, was highest at sites of osteolysis, lower at adjacent sites or distant sites and even less in muscle ( Fig. 2 A, B ). When the patients with knee prosthesis and those with hip prosthesis were analysed separately, again highest expression of cathepsin K was seen at osteolytic sites, and lowest in muscle. Gene expression at the respective sites did not differ between the two groups (data not shown). The metalloproteinases MMPI and MMP9 were highly expressed at osteolytic or directly adjacent sites ( Fig. 2 C, D) and hence co-distributed with cathepsin K (the distribution was statistically significant according to Fisher's exact test with p=0.0003 and 0.003, respectively) ( Fig. 2 E, F ). In the same tissues, cytokine gene expression was determined and with exception of CXCL 10 and CXCL2, there was a trend towards higher expression at osteolytic or adjacent sites compared to distant sites or muscle. Due to the large variance of the absolute numbers, this trend was only seen when individual patients were considered; when viewed as groups, the mean and median values suggested differences which, however, did not reach statistical significance (data summarised in Table II) . CD 14 as an indicator of monocytes was found at osteolytic and adjacent sites (Table II) . Gene expression of CD 14 correlated closely with that of CCL2 and CXCL2 (p= 0.0001), and moderately with CXCL8, S100A9, cathepsin K and RANK (p < 0.025) (all calculated with Fisher's exact test). CD3 as an indicator for T lymphocytes was found in all tissues, even in muscle with no clear preference. CD3 gene expression correlated with that of CXCLIO (p=O.OOOI), which suggests the T cells were activated to some extent (Table II) .
Cathepsin K and cytokine gene expression in patients with infected implants with or without osteolysis
With the same protocol, tissue of patients with bacterial implant infection was analysed. Of the ten patients, six presented with osteolysis at multiple sites (Table I) . At these sites and also at adjacent sites cathepsin K was expressed (Fig. 3A, Fig. 3B shows staining with TRAP), ( Fig. 5 A,B) , as were MMP9 and MMP 1 (Table II) . The most intriguing finding in patients with infection, however, was the prominent gene expression of CXCL8 which was found at sites of osteolysis, but expression was even more pronounced in adjacent and distant tissues ( Fig. 5 C, D) , and also around blood vessels, as shown by immunohistological staining (Fig. 3 C,  D) . Gene expression of IL-lf3 followed essentially the same pattern, as did expression of CCL2 and CXCL2, whereas the other cytokines were more or less evenly distributed (Table II) . The same was true for CD 14 and CD3 gene expression.
From the 4 patients without apparent osteolysis, tissue samples were also taken from sites around the infected implant and from distant muscle. At infected sites, again high gene expression of CXCL8, IL-If3 and CXCL2 was seen, exceeding that in muscle. Of note, gene expression of cathepsin MMP9 in infected tissue was not enhanced compared to muscle (Table III) .
To compare cathepsin K gene expression in patients with infection with or without osteolysis, we compared the numbers of transcripts in tissue derived from sites adjacent to the implant. There were 46570.1±23751.4 copies in patients with osteolysis and I I788.0±7207.6 in those without osteolysis (the difference was significant as calculated by Mann-Whitney test with p=O.OI4). Gene expression of MMPI was also higher in patients with osteolysis (5878±8983 copies vs I75.4±745.6; p=7.7xIO· 5 ) , Cathepsin K whereas expression of MMP9, CXCL8 and of the other cytokines did not differ significantly.
Comparison of implant infections with aseptic loosening
To compare cytokine gene expression in tissues derived from patients with aseptic loosening with that of patients with bacterial infection, we firstly compared expression at the respective site, and secondly, we summed up the copy numbers of all tissue samples. In the latter approach we also included the four patients with infection, but ..
• Fig. 3 . Osteoclasts in tissue from a patient with osteomyelitis. A. B) Tissue with bone (blue *) and adjacent soft tissue. Osteoclasts, either detected with an antibody to cathepsin K (A) or to TRAP (B) are found in the immediate vicinity of bone (arrows), and in the adjacent soft tissue as well (arrowheads). In the tissue ofa patient with infection and osteolysis (C) (biopsy of the joint capsule) CXCL8 positive cells are seen, presumably monocytes and PMN (thin arrows) and a prominent staining around the blood vessel (thick arrow). D) Tissuefrom the distant site, with only afew leukocytes. and blood vessels negative for CXCL8.
without apparent osteolysis. As depicted in Fig. 4 , in patients with infection, expression of CXCL8, IL-II3, CCL2 and CXCL2 exceeded that of patients with aseptic loosening, particularly when adjacent or distant tissues were compared. Gene expression of CD 14, CD3 and the other cytokines did not differ significantly (Table II) . When total gene expression of cytokines was compared, again IL-ll3 and CXCL8 expression was considerably higher in patients with infection (Table  IV) ; less impressive were the differences for TNFa, S IOOA9 and CXCL2, and the MMPs, whereas cathepsin K expression did not differ (Table IV) .
In patients with infection, CXCL8 was found, as expected, in infiltrated leukocytes; high expression of CXCL8 was also seen around blood vessels ( Fig.  3 C, D) .
DISCUSSION
Loosening of implants was associated with cathepsin K expression, particularly high in tissue derived from the osteolytic site, and significantly less in adjacent or more distant tissue or in muscle. Because cathepsin K is expressed by osteoclasts as they differentiate, the data indicate generation of osteoclasts at osteolytic sites preferentially. The causal relationship between the presence of osteoclasts and osteolysis is established by the fact that osteoclasts are the only cells capable of degrading bone, and also by the observation that
Fig. 4. Expression of CXCL8. IL-j3 and CXCL2 in tissue of patients with aseptic loosening (open boxes) or infection and osteolysis (striped boxes). Shown are boxand whiskers blots with mean and media values. The differences between the groups were calculated using Mann-Whitney test.
cathepsin K is not prominently expressed in tissue of patients with infection but without osteolysis.
In patients with osteolysis, cathepsin K gene expression correlated closely with that of the metalloproteinases MMPi and 9. These proteinases are produced by monocytes, but also by osteoclasts as they differentiate from their precursor cells (il-i3) and their participation in bone degradation has been established in various experimental models. For example, MMP9 participates in bone turnover by supporting osteoclast migration (13, i4 ).
Among the cytokines expressed at the osteolytic sites, CCL2, CXCL2 and CXCL8 are not only chemokines, but also known to enhance or to induce osteoclast generation, respectively. By doing so, infiltrating monocytes could promote osteoclast generation and thus provide the link between local inflammation and generation of bone-resorbing osteoclasts, particularly because aside from resident myeloid cells, also peripheral-blood monocytes can be activated to differentiate towards an osteoclastic phenotype (15, 16) . The latter explains that osteoclasts are also found in tissues distant from bone, even in muscle. The fact that infiltrated cells via release of chemokine can attract more monocytic cells with the capacity to differentiate to osteoclasts could explain the progressive nature of septic and aseptic loosening.
Gene expression of RANK and RANKL was rather moderate in osteolytic tissue, which was somewhat unexpected because RANKL and its interaction with RANK on osteoclast precursors were implied as major inducers of bone resorption in chronic inflammatory diseases or in patients with bone tumours or bone metastases (10, 17) . Low numbers of transcripts, however, do not rule out a participation of RANK-RANKL, especially because RANK is constitutively expressed by osteoclast precursors and only modestly upregulated.
Tissues of patients with aseptic loosening and those derived from implant infection with osteolysis displayed essentially a similar cytokine gene expression pattern. CXCL8, however, was greatly enhanced in patients with infection. Of note, highest CXCL8 gene expression, exceeding that of patients with aseptic loosening by 10-to 20-fold, was seen in adjacent and distant tissues. CXCL8 is a very versatile molecule, which on one hand participates in cell trafficking and recruitment of cells to infectious sites, but it also induces the differentiation of precursor cells to osteoclasts, and might therefore directly link bacterial infection to bone degradation (18, 9) . In addition to CXCL8, also expression ofIL-IB, CXCL2 and Sl00A9 was enhanced in patients with infection, though less prominently. Infiltrating leukocytes are a likely source for these proinflammatory cytokines. Whereas monocytes are found in both, aseptic loosening and bacterial infection, neutrophils are seen in infected tissue only, not only osteolytic sites but also in surrounding tissue. Because neutrophils produce, among others, IL-IB, CXCL8 and MRP-14 (19, 20) , their presence could explain the abundance of these cytokines in infected tissue compared to tissue of patients with aseptic loosening.
Another source of CXCL8 could be endothelial cells. Under inflammatory conditions, endothelial cells synthesize and release CXCL8 and they also bind it to their surface (21, 22) , where CXCL8 apparently affects various endothelial cell functions, and participates in cell trafficking (23) . In biopsies of patients with infections, but not in those derived from patients with aseptic loosening, CXCL8 was found around blood vessels (Fig. 3C ). From the biopsies we cannot decide whether or not it was synthesised there or whether exogenously generated CXCL8 had bound to the cells. De novo synthesis by endothelial cells, however, could explain the high copy numbers for CXCL8 in tissue distant from the implant.
CXCL8, IL-I B, CXCL2 and S100A9 were also highly expressed in tissue of patients with infection and without osteolysis, whereas in these patients expression of cathepsin K, MMP 1and MMP9 was not different from that in muscle, and was also lower compared to gene expression at osteolytic sites. These data underline the link between osteolysis and osteoclast generation and, on the other hand, the connection between cytokine generation, particularly of CXCL8, and infection.
Although loosening of implants is multifactorial in nature, depending for example on quality, location and wear of the implant, as well as on patients' inherent properties, aseptic and septic loosening share basically similar mechanisms, namely a local inflammatory response with generation ofosteoclasts. Phagocytosis of particulate material, bacteria in case of infection, wear particles derived from the implant in aseptic patients could be the common initiating event, because phagocytosis invariably leads to the generation and release ofproinflammatory cytokines, and the proinflammatory environment then supports osteoclast generation. Because the initial insultwear particles or bacteria -persists, the inflammatory process does not resolve, but progresses as does bone resorption.
